Skip to main content
. 2022 Jun 15;10(5):1128–1136. doi: 10.1016/j.jvsv.2022.04.019

Table I.

Characteristics of patients who were on low-molecular-weight heparin (LMWH) vs unfractionated heparin (UFH) prophylactic vs therapeutic level of AC

LMWH UFH P value
SOFA prophylactic (mean ± SD) 5.8 ± 0.23 4.09 ± 0.95 .04
SOFA therapeutic (mean ± SD) 5.8 ± 0.24 7.6 ± 0.25 .5
Max D-dimer for prophylactic (mean ± SE) 3472 ± 458 3223 ± 989 .64
Max D-dimer for therapeutic (mean ± SE) 12,672 ± 1618 11,743 ± 1470 .67
Admit creatinine for prophylactic (mean ± SE) 0.99 ± 0.11 1.34 ± 0.25 .14
Admit creatinine for therapeutic (mean ± SE) 0.98 ± 0.06 1.9 ± 0.25 .001
Max creatinine for prophylactic (mean ± SE) 1.46 ± 0.18 3.18 ± 0.7 .017
Max creatinine for therapeutic (mean ± SE) 1.37 ± 0.1 4.63 ± 0.34 .001
Max CRP, prophylactic (mean ± SE) 36.18 ± 4.9 39.49 ± 13.7 .97
Max CRP, therapeutic (mean ± SE) 40.4 ± 4.3 39.7 ± 3.8 .88
Max interleukin 6 (Vivacor), prophylactic (mean ± SE) 218 ± 70 1949 ± 1134 .003
Max interleukin 6 (Vivacor), therapeutic (mean ± SE) 428 ± 120 284 ± 73 .6

AC, Anticoagulation; CRP, C-reactive protein; SD, standard deviation; SE, standard error; SOFA, Sequential Organ Failure Assessment.

Boldface P values represent statistical significance.